Electrophysiological Signature of Mild Cognitive Impairment and Its Relationship with Parkinson's Disease: a High-density EEG Investigation
IRCCS San Camillo, Venezia, Italy
42 participants
Jun 18, 2023
OBSERVATIONAL
Conditions
Summary
The study aims to investigate neural correlate of Mild Cognitive Impairment (MCI) in Parkinson's disease (PD) and to identify a link between functional impairment (in both cognitive and motor domains) and electrophysiological cortical sing of MCI in PD. A sample of 42 subjects will be divide into three subgroup: healthy control, PD with MCI (PD-MCI) and PD without MCI (PD-ctrl). Those subjects will undergo a specific neuropsychological evaluation and, to measure the electro-cortical activity, high-density electroencephalography (hdEEG) will be record during both resting state and cognitive tasks. Furthermore, hdEEG data will be combine with structural magnetic resonance to obtain information about network connectivity.
Eligibility
Inclusion Criteria3
- Upper score \>24 MMSE or \>15.5 Moca
- If taking medications, taking stable doses for at least 4 weeks prior to the inclusion visit - of anticholinesterase drugs (donepezil, memantine, rivastigmine, ...) or antidepressants (SSRIs, tricyclics, SNARI, ...) or Levodopa.
- Having signed the informed consent
Exclusion Criteria6
- Subjects with severe dementia ( MMSE \< 24 )
- Lower score \<15.5 Moca
- Subjects on antipsychotic treatment for less than 3 months
- Subjects with uncontrolled comorbidities
- Subjects with metal prostheses or dentures and in general conditions for which MRI examinations are prevented.
- Subjects with an inability to walk independently.
Interventions
Subjects undergo a clinical and neuropsychological assesment, then a Hd-EEG both during resting state and execution of tasks, and structural Magnetic Resonance Imaging
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06640673